Dealing with a narcissist can be emotionally draining, challenging, and mind-numbing. It severely harms your ability to think and act rationally, slowly depleting your self-esteem and well-being. Whether it is a romantic partner, family member, or friend learning how to deal with a narcissist is crucial for your emotional and mental well-being. In this comprehensive […]
The post How To Effectively Deal with a Narcissist first appeared on The Holistic Living.
- April 24, 2024
- 0 Comment
Continue reading "7 biotin-rich foods for glowing skin and hair growth"
- April 24, 2024
- 0 Comment
Nature Medicine, Published online: 23 April 2024; doi:10.1038/s41591-024-02942-7
In a phase 2 trial, nivolumab achieved a response rate of 58% in patients with mismatch-repair-deficient gynecological cancers, meeting the primary endpoint, and genomic and immunologic features correlated with response.- April 23, 2024
- 0 Comment
Nature Medicine, Published online: 23 April 2024; doi:10.1038/s41591-024-02906-x
QR4 is a new cardiovascular disease (CVD) risk score developed and evaluated in 16.9 million people that has better performance than other commonly used CVD risk scores. It includes nine new risk factors associated with increased risk of developing CVD (for example, a heart attack or stroke) over the next 10 years.- April 23, 2024
- 0 Comment
- April 22, 2024
- 0 Comment
Nature Medicine, Published online: 22 April 2024; doi:10.1038/s41591-024-02998-5
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results- April 22, 2024
- 0 Comment
Nature Medicine, Published online: 22 April 2024; doi:10.1038/s41591-024-02922-x
Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies- April 22, 2024
- 0 Comment
Nature Medicine, Published online: 22 April 2024; doi:10.1038/s41591-024-02952-5
Food allergy treatment is undergoing a paradigm shift with new therapies emerging, including the recent FDA approval of omalizumab — but without evidence of disease modification and with uncertain quality-of-life improvement, it may not be a panacea for all.- April 22, 2024
- 0 Comment
Nature Medicine, Published online: 22 April 2024; doi:10.1038/s41591-024-03006-6
Author Correction: Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants- April 22, 2024
- 0 Comment
Nature Medicine, Published online: 20 April 2024; doi:10.1038/d41591-024-00026-0
In a multicenter clinical trial, patients with early-stage Parkinson’s disease treated with lixisenatide, a drug currently used for the treatment of diabetes, showed improvement in their motor scores compared with those on placebo.- April 20, 2024
- 0 Comment